CelicoutB., LevardH., HayJ., MsikaS., FingerhutA., PelissierE.Sclerosing encapsulating peritonitis: early and late results of surgical management in 32 cases. French Associations for Surgical Research.Dig Surg1998; 15: 697–702.
3.
SufrinG., ChasonS., GolioA., MurphyG.Paraneoplastic and serologic syndrome of renal carcinoma.Semin Urol1989; 7: 158–71.
4.
ShaldonS., KochK.M., QuellhorstE., DinarelloC.A.Pathogenesis of sclerosing peritonitis in CAPD.ASAIO Trans1984; 30: 193–4.
5.
LinC.Y., ChenW.P., YangL.Y., ChenA., HuangT.P.Persistent transforming growth factor-beta 1 expression may predict peritoneal fibrosis in CAPD patients with frequent peritonitis occurrence.Am J Nephrol1998; 18: 513–19.
6.
KangD.H., HongY.S., LimH.J., ChoiJ.H., HanD.S., YoonK.I.High glucose solution and spent dialysate stimulate the synthesis of transforming growth factor beta 1 of human peritoneal mesothelial cells: effect of cytokine co-stimulation.Perit Dial Int1999; 19: 221–3.
7.
GunalA.I., GezenM., OzercanR., OnerH., CelikerH.The effect of octreotide on peritoneal alterations induced by high concentrations of glucose.Perit Dial Int1998; 18: 532–40.
8.
DobbieJ.W.. Pathogenesis of peritoneal fibrosing syndromes (sclerosing peritonitis) in peritoneal dialysis.Perit Dial Int1992; 12: 14–27.
9.
BargmanJ.M.Non-infectious complications of peritoneal dialysis. In: GokalR., NolphK.D., eds. The Textbook of Peritoneal Dialysis.Dordrecht: Kluwer Academic Publishers;1994: 555–90.
10.
BreborowiczA., RodelaH., KaronJ., MartisL., OreopoulosD.G.In vitro stimulation of the effect of peritoneal dialysis solution on mesothelial cells.Am J Kidney Dis1997; 29: 404–9.
11.
RippeB., StelinG., HaraldssonB.Computer simulations of peritoneal fluid transport in CAPD.Kidney Int1991; 40: 3315–25.
12.
YangB., FolkessonH.G., YangJ., MatthayM.A., MaT., VerkmanA.S.Reduced osmotic water permeability of the peritoneal barrier in aquaporin-1 knockout mice.Am J Physiol1999; 267: C76–81.
13.
ImaiH., NakamotoH., IshidaY., InoueT., KannoY., OkadaH.Glucocorticoid restores the deterioration of water transport in the peritoneum through increment in aquaporin.Adv Perit Dial2000; 16: 297–302.
14.
CampbellS., ClarkeP., HawleyC., WiganM., ButlerJ., WallJ.Sclerosing peritonitis: identification of diagnostic, clinical and radiological features.Am J Kidney Dis1994; 24: 819–25.
15.
HendriksPMEM, Ho-dac-PannekeetM.M., van GulikT.M., StruijkD.G., PhoaSSKS, SieL.Peritoneal sclerosis in chronic peritoneal dialysis patients: analysis of clinical presentation, risk factors, and peritoneal transport kinetics.Perit Dial Int1997; 17: 136–43.
16.
AfthentopoulosI.E., PassadakisP., OreopoulosD.Sclerosing peritonitis in continuous ambulatory peritoneal dialysis patients: one center's experience and review of the literature.Adv Ren Replace Ther1998; 5: 157–67.
17.
OulesR., ChallahS., BrunnerF P.Case control study to determine the cause of sclerosing peritoneal disease.Nephrol Dial Transplant1988; 3: 66–9.
18.
RigbyR.J., HawleyC.M.Sclerosing peritonitis: the experience in Australia.Nephrol Dial Transplant1998; 13: 154–9.
19.
ArakiY., HatayaH., TanakaY., FukuzawaR., IkedaM., KawamuraK.Long-term peritoneal dialysis is a risk factor of sclerosing encapsulating peritonitis for children.Perit Dial Int2000; 20: 445–51.
20.
YamamotoT., IzumotaniT., OtishiT., KimT.Morphological studies of mesothelial cells in CAPD effluent and their clinical significance.Am J Kidney Dis1998; 32: 946–52.
21.
GarosiG., Di PaoloN.Peritoneal sclerosis: one or two nosological entities?Semin Dial2000; 13: 297–308.
22.
NakayamaM., KawaguchiY., YamadaK., HasegawaT., TakazoeK., KatohN.Immunohistochemical detection of advanced glycosylation end products in the peritoneum and its possible pathophysiological role in CAPD.Kidney Int1997; 51: 182–6.
23.
KredietR.T., StruijkD.G., BoeschotenE.W., KoomenG.C.M., StouthardJ.M.L., HoekF.J.The time course of peritoneal transport kinetics in continuous ambulatory peritoneal dialysis patients who develop sclerosing peritonitis.Am J Kidney Dis1989; 13: 299–307.
24.
HollmanA.S., McMillanM.A., BriggsJ.D., JunorB.J.R., MorleyP.Ultrasound changes in sclerosing peritonitis following continuous ambulatory peritoneal dialysis.Clin Radiol1991; 43: 176–9.
25.
JoffeP., JensenL.T.Type I and III procollagens in CAPD: markers of peritoneal fibrosis.Adv Perit Dial1991; 7: 158–60.
26.
SlingeneyerA., ElieM., MionC.Sclerosing encapsulating peritonitis: results of an international survey (Abstract).Nephrol Dial Transplant1986; 1: 112.
27.
BhandariS., WilkinsonA., SellarsL.Sclerosing peritonitis: value of immunosuppression prior to surgery.Nephrol Dial Transplant1994; 9: 436–7.
28.
PusateriR., RossR., MarshallR., MeredithJ.H., HamiltonR W.Sclerosing encapsulating peritonitis: report of a case with small bowel obstruction managed by long-term home parenteral alimentation, and a review of the literature.Am J Kidney Dis1986; 13: 56–60.
JunorB.J.R., McMillanM.A.Immunosuppression in sclerosing peritonitis.Adv Perit Dial1993; 9: 187–9.
32.
HawleyC.M., WallD.R., JohnsonD.W., CampbellS.B., GriffinA.D., RigbyR.J.Recovery of gastrointestinal function after renal transplantation in a patient with sclerosing peritonitis secondary to continuous ambulatory peritoneal dialysis.Am J Kidney Dis1995; 26: 658–61.
33.
GenereauT., BellinM.F., WechslerB., LeT.H., BellangerJ., GrelletJ.Demonstration of efficacy of combining corticosteroids and colchicine in two patients with idiopathic sclerosing mesenteritis.Dig Dis Sci1996; 41: 684–8.
34.
StruijkD.G., van der ReijdenH.J., KredietR.T., KoomenG.C., AriszL.Effect of phosphatidylcholine on peritoneal transport and lymphatic absorption in a CAPD patient with sclerosing peritonitis.Nephron1989; 51: 577–8.
35.
MazureR., Fernandez MartyP., NiveloniS., PedreiraS., VazquezH., SmecuolE.Successful treatment of retractile mesenteritis with oral progesterone.Gastroenterology1998; 114: 1313–17.
36.
VenkataramaniA., BehlingC.A., LycheK.D.A.Sclerosing mesenteritis: an unusual cause of abdominal pain in an HIV-positive patient.Am J Gastroenterol1997; 92: 1059–60.
37.
DoodyK.J., DunnR.C., ButramV.C.Recombinant tissue plasminogen activator reduces adhesion formation in a rabbit uterine horn model.Fertil Steril1989; 51: 509–12.
38.
SugaH., TeraokaS., OtaK., KomemushiS., FurutaniS., YamauchiS.Preventative effect of pirfenidone against experimental sclerosing peritonitis in rats.Exp Toxicol Pathol1995; 47: 287–91.
